Key points are not available for this paper at this time.
= 0.26). Knowing the severity of different pDDIs will help clinicians and prescribers monitor patient safety through regular monitoring for interactions and adverse drug effects in future. The number of medications and polypharmacy was found to be the most significant predictor of pDDIs.
Aburamadan et al. (2021) studied this question.